Skip to main content
The BMJ logoLink to The BMJ
. 2004 Jun 5;328(7452):1358–1362. doi: 10.1136/bmj.328.7452.1358

Management of venous leg ulcers

Deborah A Simon 1, Francis P Dix 1, Charles N McCollum 1
PMCID: PMC420292  PMID: 15178615

Leg ulcers are a big problem for both patients and health service resources.1-3 Most ulcers are associated with venous disease, but other causes or contributing factors include immobility, obesity, trauma, arterial disease, vasculitis, diabetes, and neoplasia (box 1). In the United Kingdom, venous leg ulceration alone has been estimated to cost the NHS £400m ($720m; €600m) a year.1-3 Much of this cost is accounted for by community nursing services; district nurses spend up to half of their time caring for patients with ulcers.1,4

Most venous leg ulcers could be healed if patients were admitted to hospital for continuous leg elevation. Shortage of hospital beds, the high cost of inpatient care, and the need to maintain independence in this elderly population of patients mean that this once popular approach is now rarely practical.2 Furthermore, ulcers often recur when the patient returns home and resumes a lifestyle in which most of the day is spent with the legs in dependency.w1 Outpatient systems of care that maintain mobility and avoid the complications of bed rest are more cost effective and appropriate. Outpatient and community based care also maintain independence and quality of life.

Care for patients with leg ulcers has improved in the past two decades as research based approaches have been adopted. Community leg ulcer clinics using compression bandaging have dramatically improved healing rates and reduced costs, but close supervision by leg ulcer nurse specialists is essential if standards are to be maintained.1,2,5 We have reviewed the evidence for this approach and on new treatments that may improve care of leg ulcers in the future.

Sources and search criteria

We compiled material for this review from published literature located by online searches of Medline, PubMed, and Embase using the terms “leg ulcer management,” “treatment of leg ulcer,” and “leg ulcer.” We also sourced references quoted in these original papers and examined Cochrane reviews on leg ulcers.

Causes of venous ulceration

The pathophysiology of venous ulceration is contentious, and detailed consideration of the microcirculatory changes leading to tissue necrosis is beyond the scope of this review. However, management must be based on an understanding of the causes of the venous hypertension that is ultimately responsible for both the symptoms of chronic venous insufficiency and venous ulceration. Chronic venous insufficiency has been widely assumed to be due to deep venous obstruction or incompetence, and the term “post-phlebitic limb” has been used, even though most people with venous ulcers have no history of deep vein thrombosis. Venous ulceration is clearly associated with age, and younger patients with severe chronic venous insufficiency may avoid ulceration by virtue of their mobility, which maintains function of the calf muscle pump. Whether the final mechanism in ulceration is a fibrin cuff, leucocyte trapping, or chronic inflammation due to a repetitive ischaemia reperfusion injury, the treatment for venous ulceration is based almost entirely on avoiding sustained venous hypertension.6 Venous hypertension is usually caused by a combination of the factors given in box 2, of which venous disease, obesity, and immobility are perhaps the most important; many factors develop with increasing age.

Summary points

Care of patients with venous leg ulcers has been improved by a research based approach

Most venous ulcers can be managed by compression bandaging in the community

Supervision by leg ulcer nurses is essential if standards are to be maintained in community leg ulcer services

Future research should focus on preventing ulceration by identifying at risk populations

Sustained venous hypertension results in oedema within the dependent lower limb, which increases the distance over which metabolites must diffuse from the microcirculation to tissue cells. The tissues around the ankle become ischaemic during dependency, with reperfusion on walking or elevation.7 This chronic reperfusion injury results in an inflammatory process with further oedema, tissue fibrosis, and formation of a cuff of extracellular matrix proteins around capillaries. These changes result in the features of chronic venous insufficiency, which include aching, heaviness of the legs, itching, lipodermatosclerosis, pigmentation, swelling, eczema, and ultimately ulceration (fig 1). Treatment is based on preventing sustained venous hypertension and reducing its effects by compression bandaging to reduce venous stasis and tissue oedema.

Fig 1.

Fig 1

This superficial leg ulcer, in the classic position above the medial malleolus, has healthy granulation tissue after two weeks of compression treatment. The features of lipodermatosclerosis with pigmentation can be seen at the upper margin

Box 1: Causes of leg ulcers

Vascular

  • Venous—80-85% of all leg ulcers

  • Arterial—atherosclerosis, arteriovenous malformation

  • Vasculitis—systemic lupus erythematosis, rheumatoid arthritis, scleroderma, polyarteritis nodosa, Wegener's granulomatosis

  • Lymphatic

Neuropathic

Diabetes, peripheral neuropathy—usually feet

Haematological

Polycythaemia rubra vera, sickle cell anaemia

Traumatic

Burns, cold injury, pressure sore, radiation, factitious

Neoplastic

Basal or squamous cell carcinoma, melanoma, Marjolin's ulcer, Bowen's disease

Others

Sarcoidosis, tropical ulcer, pyoderma gangrenosum

Diagnosis and investigation

Management must start with a full history and examination to identify risk factors such as age, sex, cardiovascular disease, body mass index, mobility, arthritis, diabetes, and a history of leg injury or deep vein thrombosis. Leg ulceration can be defined as any chronic ulcer on the lower leg but excluding those on the forefoot or toes.w2

The patient should be examined both lying and standing to detect varicose veins. Hand held Doppler is essential to measure the ankle brachial pressure index to exclude arterial disease (ankle brachial pressure index > 0.9) and assess superficial venous reflux.w3 Venography gave little functional information and has been superseded by duplex imaging, which is indicated for patients with recurrent or complicated varicose veins, short saphenous incompetence, or suspected deep venous disease.8 Superficial venous incompetence is almost universal and is the predominant cause of venous hypertension in approximately half of limbs with venous ulcers, particularly in younger patients with good mobility.9 Venous function in patients with mixed deep and superficial disease should be investigated by ambulatory venous pressure measurements.10 This involves cannulation of a foot vein and the use of tourniquets to occlude incompetent superficial veins to select those patients who may benefit from superficial venous surgery.

Box 2: Causes of sustained venous hypertension

• Venous disease:

Superficial venous incompetence—varicose veins

Deep venous incompetence

Primary Deep venous obstruction (rare)

Previous deep vein thrombosis

External compression

• Impaired calf muscle pump function:

Immobility

Joint disease

Paralysis

Obesity—immobility, femoral vein compression, high abdominal pressures

• Congestive cardiac failure

Box 3: Effective treatment for venous leg ulcers

  • Four layer compression bandaging

  • Leg elevation

  • Improve mobility

  • Reduce obesity

  • Improve nutrition

  • Skin grafting in selected patients

  • Venous surgery in selected patients

Management of the ulcer

Despite considerable research, little evidence of major benefits from modern interactive dressings has been published. An emphasis on education, training, and further development of compression systems is needed to improve patient care and ulcer healing. The basis for effective treatment of venous leg ulcers is outlined in box 3.

Where should care be carried out?

Patients with venous leg ulcers are best managed in the community for two reasons:

  • Maintenance of independence and mobility is important in this elderly population

  • The number of patients would overwhelm hospital services.1,2

However, direct access to appropriate specialised hospital services is essential for the investigation of underlying vascular disease and for microbiology, histopathology, and dermatology. Having said that, leg ulcer services provided in hospitals often fail to appreciate how many patients with leg ulcers simply refuse to come to hospital, let alone consent to venous investigation or surgery.1,2 Few community patients are prepared to be referred for assessment of their underlying venous disease.1,2,5

Rates of healing have been shown to be improved and costs to be reduced when a coordinated service using research based protocols was introduced.1,2,5,11 Responsibility for patient care should not be removed from community nurses; they should be provided with resources and training aimed at delivering an appropriate, high quality service in specialist leg ulcer clinics. Evidence from our own research in two large health authorities in the United Kingdom showed that standards could be maintained only with close supervision; when a leg ulcer service was continued without the direct involvement of a leg ulcer nurse specialist, healing rates declined and costs increased.5

Treating the ulcer

The underlying causes need to be identified (box 2). Multiple pathologies are common, but patients with diabetes may have simple venous ulcers that are no more difficult to heal than in people without diabetes. As 80-85% of ulcers are associated with venous hypertension, compression remains the mainstay of treatment.12 w4

Dressing materials

Patients with leg ulcers are prone to contact sensitivity, particularly from wool alcohols, topical antibiotics, cetylstearyl alcohols, parabens, and rubber mixes, which are present in many dressings, ointments, and creams.w5 Many entirely inadequate studies have examined the role of different dressing materials; most have shown that modern “designer” dressing materials have no additional effect on wound healing over that achieved by simple low adherence dressings under multilayer compression bandaging.w6

Compression treatment

Sustained graduated compression overcomes the effects of venous hypertension by reducing venous stasis and preventing (or treating) tissue oedema. The pressure within the veins on standing is largely hydrostatic, and the level of external pressure needed to counteract this decreases progressively up the leg.

Compression treatment has been covered in a Cochrane review on the cost effectiveness of both bandaging and stockings in the treatment of venous ulceration.13 Twenty two trials were identified and consistently showed that compression encouraged healing of ulcers.13 More ulcers were healed at 12-15 weeks with high compression systems than with low compression systems.13 No significant difference was found between the effectiveness of different high compression systems, but more ulcers healed at 24 weeks with four layer bandages than with a single layer.w7

The most effective level of compression to overcome venous hypertension has been determined to be around 40 mm Hg at the ankle.w8 Correct application of bandages is essential to avoid pressure ulceration over bony high points and along the anterior border of the tibia. To achieve this pressure in a range of limb diameters, bandaging regimens must be adjusted according to ankle circumference (fig 2). Despite training, community nurses have been found to abandon ankle circumference measurements when not closely supervised by a venous nurse specialist.5

Fig 2.

Fig 2

The combination of compression bandages used to achieve compression of 40 mm Hg at the ankle will depend on ankle circumference according to Laplace's law. A combination of bandages achieving ideal pressures in the average ankle will produce ineffective pressures in a large oedematous limb and dangerously high pressures risking skin necrosis over bony high points in small or narrow ankles

As venous ulcer services improve, more patients have their ulcers healed and are then at risk of recurrence; recurrence rates of 26% at one year and 31% at 18 months have been quoted.14 A Cochrane review on the role of compression in the prevention of recurrence identified few adequate trials, but concluded that recurrence may be lower with higher compressions.15

Limb elevation

Limb dependency, immobility, and oedema all contribute to venous hypertension. Limb elevation reduces oedema and enhances flow in the microcirculation, reducing trapping, sequestration, and activation of white cells—a necessary first step in the pathophysiology of ulceration.w9 Leg elevation in hospital enhances healing.w1

Skin grafting

Split skin grafting is technically demanding and requires hospital admission. The discharge from the surface of venous ulcers tends to dislodge continuous sheets of split skin, leaving a choice between mesh and pinch skin grafting.w10

Box 4: Indications for superficial venous surgery

  • Patient fit for surgery (local anaesthesia if necessary)

  • Sufficient mobility to activate calf muscle pump

  • Prepared to attend hospital for investigation and surgery

  • Obesity controlled (body mass index < 30)

  • Superficial venous incompetence: no deep venous incompetence on duplex imaging, or predominantly superficial venous incompetence on ambulatory venous pressures with tourniquet occlusion of the superficial veins

Information resources for patients and professionals

Tissue Viability Society (www.tvs.org.uk/Booklets/legulcers.html)—Aims to raise standards in the prevention and treatment of chronic wounds Vascular Surgical Society (www.vssgbi.org/patientinfo/legulcer.html)—Information resource for doctors and patients

British Vascular Foundation (www.bvf.org.uk/cond_explained.htm)—Information resource for healthcare professionals and patients

Patient UK (www.patient.co.uk/showdoc.asp?doc=23068777)—Useful resource for patients

Pinch skin grafts provide epithelial islands, from which epithelial growth may spread outwards as well as inwards from the ulcer margin. Pinch skin grafting has been done by district nurses in the community and has been found to be cost effective, accelerating healing when used with multilayer compression bandaging (fig 3).w11 w12

Fig 3.

Fig 3

Fig 3

Pinch skin grafts applied two weeks previously are growing halos of new epithelium that are beginning to merge (top). Only one week later, perhaps as a result of growth factors from healing epithelium, almost complete healing has been achieved (bottom)

Bioengineered skin products, including bilayered skin constructs and frozen human allogeneic epidermal cultures, are being developed and may stimulate wound healing through the release of growth factors and cytokines. The numbers of patients recruited to such studies have been small, and most products are not yet available for clinical use.w13 w14 These new approaches have yet to be compared with pinch skin grafting, which is simple and inexpensive.w12

Growth factors

Wound fluid from non-healing ulcers contained higher concentrations of pro-inflammatory cytokines, interleukin-1, interleukin-6, and tumour necrosis factor-α and had reduced proliferative responses compared with fluid from healing ulcers.16 Research on platelet derived growth factor, hepatocyte growth factor, and human keratinocyte growth factor-2 has been published, but these studies were small and often poorly designed.17 w15 w16

Drug treatment

Antibiotics have little effect on ulcer healing but are needed for clinical infections with surrounding cellulitus.w17 Pentoxifylline has been evaluated in clinical trials, but the largest placebo controlled, double blind, randomised study included only 80 patients; 88% were healed by 12 months on pentoxifylline compared with 44% on placebo.18 Oxerutins failed to improve ulcer healing or influence recurrence.19 w18 Fibrinolytic agents such as stanozolol have also been disappointing.w18 Studies on prostaglandin E1 and micronised purified flavonoids were simply too small to influence clinical practice.w19 w20 Sulodexide is a profibrinolytic and antithrombotic drug that was evaluated in a clinical trial that recruited 94 patients and achieved healing rates at two months of 58%, compared with 36% in controls (P = 0.03).20 Aspirin has also been studied in a randomised trial and significantly improved healing, but only 20 patients were randomised.21 In both the above studies, the healing rate achieved with drugs was no better than that achieved without drug treatment in community leg ulcer clinics.1,2

Venous surgery

Superficial venous surgery has been shown to improve ulcer healing in patients with only superficial venous incompetence.22 In patients with no deep reflux on duplex imaging, superficial venous surgery also reduced ulcer recurrence at three years from 44% to 26% in a non-randomised study.23 When superficial venous surgery was compared with compression alone in 87 patients with venous ulcers, surgery achieved complete healing at a mean of 31 days compared with 63 days with compression; recurrence rates at three years were 9% and 38%.24 Box 4 shows indications for superficial venous surgery.

A patient's perspective

I developed an ulcer on my right leg in 1992. It started when I kicked my right ankle with the heel of my left shoe. This broke the skin, and very soon the wound became infected. I went to my general practitioner and had the wound dressed by a nurse at the surgery. This went on for several weeks, but the wound would not heal. My doctor then decided to send me to hospital, where a new treatment was being used with great success. This was compression bandaging. I attended the hospital ulcer clinic for a time until a local clinic was opened in an area near to where I live. I attended the clinic once a week to have my leg bandaged. This was not always done by the same nurse, and the tension in the bandaging varied. After some time they told me that the bandaging did not suit my condition. I was then put into compression stockings, but the ulcer got bigger. I must mention that at this time I had rheumatoid arthritis and was on a lot of medication for it. I was told that this affected the healing process. The ulcer on my leg became very badly infected, and I was in a lot of pain. It was then discovered that I had MRSA, and the district nurse had to attend to my bandaging at home. As the ulcer was getting worse, I was then referred to the ulcer clinic at Withington Hospital. After many setbacks, with infection and many different antibiotics, it was suggested that because of my ankle size I needed a different combination of bandages to get the pressure I needed for the ulcer to heal. With this, coupled with leg elevation when sitting and in bed, my leg started to improve. It did take time, but I am pleased to say that my leg has completely healed. Four layer bandaging did work in the end, but the same nurse did it all the time and used consistent tension of bandaging.

The role of surgery in mixed superficial and deep venous incompetence is less clear. In unselected patients with combined superficial and deep incompetence, superficial surgery without postoperative compression failed to improve venous hypertension or achieve ulcer healing.25 However, where the deep incompetence was limited or “segmental” improvements in healing were achieved.26 Ambulatory venous pressures may help to identify patients who would benefit from surgery. Virtually no research has been done on prophylactic surgery to prevent ulceration in at risk patients with superficial venous incompetence.

Future research

Research is currently focused on the role of superficial venous surgery and the use of cultured skin allografts. The level of compression needed to optimise healing should be explored. On a microvascular level, the wound healing process is thought to be directed by a variety of cell derived soluble factors, including cytokines (growth, regulatory, and chemotactic factors) and proteolytic enzymes (proteases); these will inevitably become future targets for specific treatments.16 Ultimately, our focus should move from treating active ulcers to the prevention of ulceration by identifying at risk populations. Prevention would undoubtedly be cheaper than cure and would also improve quality of life for patients with chronic venous hypertension at risk of ulceration.

Supplementary Material

Extra references
bmj_328_7452_1358__.html (3.5KB, html)

Inline graphicExtra references are on bmj.com

Contributors: DAS and FDP did the literature review. All authors contributed to writing the paper.

Competing interests: None declared.

References

  • 1.Moffatt CJ, Franks PJ, Oldroyd MI, Bosanquet N, Brown P, Greenhalgh RM, et al. Community clinics for leg ulcers and impact on healing. BMJ 1992;305: 1389-92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Simon DA, Freak L, Kinsella A, Walsh J, Lane C, Groarke L, et al. Community leg ulcer clinics: a comparative study in two health authorities. BMJ 1996;312: 1648-51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ruckley CV. Socio-economic impact of chronic venous insufficiency and leg ulcers. Angiology 1997;48: 67-9. [DOI] [PubMed] [Google Scholar]
  • 4.Lees TA, Lambert D. Prevalence of lower limb ulceration in an urban health district. Br J Surg 1992;79: 1032-4. [DOI] [PubMed] [Google Scholar]
  • 5.Ellison DA, Hayes L, Lane C, Tracey A, McCollum CN. Evaluating the cost and efficacy of leg ulcer care provided in two large UK health authorities. J Wound Care 2002;11: 47-51. [DOI] [PubMed] [Google Scholar]
  • 6.Greenwood JE, Edwards AT, McCollum CN. The possible role of ischaemic reperfusion in the pathogenesis of chronic venous ulceration. Wounds 1995;7: 211-9. [Google Scholar]
  • 7.Herrick SE, Sloan P, McGurk, Freak L, McCollum CN, Ferguson MWJ. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol 1992;141: 1085-95. [PMC free article] [PubMed] [Google Scholar]
  • 8.Campbell WB, Halim AS, Aertssen A, Ridler BMF, Thompson JF, Niblett PG. The place of duplex scanning for varicose veins and common venous problems. Ann R Coll Surg Engl 1996;78: 490-3. [PMC free article] [PubMed] [Google Scholar]
  • 9.Grabs AJ, Wakeley MC, Nyameke I, Ghauri ASK, Poskitt KR. Colour duplex ultrasonography in the rational treatment of chronic venous leg ulcers. Br J Surg 1996;83: 1380-2. [DOI] [PubMed] [Google Scholar]
  • 10.Payne SPK, London NJM, Newland CJ, Thrush AJ, Barrie WW, Bell PRF. Ambulatory venous pressure: correlation with skin condition and role in identifying surgically correctible disease. Eur J Vasc Endovasc Surg 1996;11: 195-200. [DOI] [PubMed] [Google Scholar]
  • 11.Morrell CJ, Walters SJ, Dixon S, Collins KA, Brereton LML, Peters J, et al. Cost effectiveness of community leg ulcer clinics: randomised controlled trial. BMJ 1998;316: 1487-91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Blair SD, Wright DDI, Backhouse CM, Riddle E, McCollum CN. Sustained compression and the healing of chronic ulcers. BMJ 1988;297: 1159-61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Cullum N, Nelson EA, Fletcher AW, Sheldon TA. Compression for venous leg ulcers. Cochrane Database Syst Rev 2004;(2): CD000265. [DOI] [PubMed]
  • 14.Franks PJ, Oldroyd MI, Dickson D, Sharp EJ, Moffatt CJ. Risk factors for leg ulcer recurrence: a randomized trial of two types of compression stocking. Age Ageing 1995;24: 490-4. [DOI] [PubMed] [Google Scholar]
  • 15.Nelson EA, Bell-Syer SEM, Cullum NA. Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev 2004;(2): CD002303. [DOI] [PubMed]
  • 16.Trengrove NJ, Bielefeldt-Ohmann H, Stacey MC. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 2000;8: 13-25. [DOI] [PubMed] [Google Scholar]
  • 17.Robson MC, Phillips TJ, Falanga V, Odenheimer DJ, Parish LC, Jensen JL, et al. Randomised trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Repair Regen 2001;9: 347-52. [DOI] [PubMed] [Google Scholar]
  • 18.De Sanctis MT, Belcaro G, Cesarone MR, Ippolito E, Nicolaides AN, Incandela L, et al. Treatment of venous ulcers with pentoxifylline: a 12 month, double-blind, placebo controlled trial—microcirculation and healing. Angiology 2002;53: 49-51. [PubMed] [Google Scholar]
  • 19.Wright DDI, Franks PJ, Blair SD, Backhouse CM, Moffatt C, McCollum CN. Oxerutins in the prevention of recurrence in chronic venous ulceration: randomized controlled trial. Br J Surg 1991;78: 1269-70. [DOI] [PubMed] [Google Scholar]
  • 20.Scondotto G, Aloisi D, Ferrari P, Martini L. Treatment of venous leg ulcers with sulodexide. Angiology 1999;50: 883-9. [DOI] [PubMed] [Google Scholar]
  • 21.Layton A, Ibbotson SH, Davies JA, Goodfield MJ. Randomised trial of aspirin for chronic venous leg ulcers. Lancet 1994;344: 164-5. [DOI] [PubMed] [Google Scholar]
  • 22.Bello M, Scriven M, Hartshorne T, Bell PRF, Naylor AR, London NJM. Role of superficial venous surgery in the treatment of venous ulceration. Br J Surg 1999;86: 755-9. [DOI] [PubMed] [Google Scholar]
  • 23.Barwell JR, Taylor M, Deacon J, Ghauri ASK, Wakely C, Phillips LK, et al. Surgical correction of isolated superficial venous reflux reduces long-term recurrence rate in chronic venous leg ulcers. Eur J Vasc Endovasc Surg 2000;20: 363-8. [DOI] [PubMed] [Google Scholar]
  • 24.Zamboni P, Cisno C, Marchetti F, Mazza P, Fogato L, Caradina S, et al. Minimally invasive surgical management of primary venous ulcers vs. compression treatment: a randomised clinical trial. Eur J Vasc Endovasc Surg 2002;25: 313-8. [DOI] [PubMed] [Google Scholar]
  • 25.Scriven JM, Hartshorne T, Thrush AJ, Bell PRF, Naylor AR, London NJM. Role of saphenous vein surgery in the treatment of venous ulceration. Br J Surg 1998;85: 781-4. [DOI] [PubMed] [Google Scholar]
  • 26.Adam DJ, Bello M, Hartshorne T, London NJM. Role of superficial venous surgery in patients with combined superficial and segmental deep venous reflux. Eur J Vasc Endovasc Surg 2003;25: 469-72. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Extra references
bmj_328_7452_1358__.html (3.5KB, html)

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES